Trial Profile
Inhaled Nitric Oxide in Prevention/Treatment of Ischemia-Reperfusion Lung Injury Related to Lung Transplantation
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 11 Sep 2016
Price :
$35
*
At a glance
- Drugs Nitric oxide (Primary)
- Indications Reperfusion injury
- Focus Therapeutic Use
- Sponsors Ikaria Holdings
- 25 May 2014 New trial record